Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Potassium Aspartate and Magnesium Aspartate [USAN:JAN]
RN: 14842-81-0
UNII: 55TUI7Q42I
InChIKey: KLISBMUDTJHGSP-AIDJSRAFSA-K

Note

  • Asparkam tablets contain potassium & magnesium aspartate.

Classification Codes

  • Drug / Therapeutic Agent
  • Nutrient

Molecular Formula

  • C8-H10-Mg-N2-O8.C4-H6-N-O4.2H.K

Molecular Weight

  • 459.686
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Asparkam
  • Potassium Aspartate and Magnesium Aspartate [USAN:JAN]

Synonyms

  • Aspara
  • L-Asparkam
  • L-Aspartic acid, monopotassium salt, mixt. with dihydrogen (T-4)-bis(L-aspartato(2-)-kappaN,kappaO1)magnesate(2-)
  • Magnesium potassium L-aspartate
  • Potassium aspartate and magnesium aspartate
  • Potassium magnesium aspartate
  • Spartase
  • Trophicard
  • UNII-55TUI7Q42I
  • Wy 2837
  • Wy 2838
  • Wy-2837
  • Wy-2838

Systematic Names

  • Aspartic acid, L-, magnesium salt (2:1) tetrahydrate, mixture with potassium hydrogen L-aspartate hemihydrate
  • L-Aspartic acid, monopotassium salt, mixt. with dihydrogen (T-4)-bis(L-aspartato(2-)-N,O(sup 1)magnesate(2-)
  • L-Aspartic acid, monopotassium salt, mixt. with dihydrogen (T-4)-bis(L-aspartato(2-)-N,O1)magnesate(2-)
  • Magnesate(2-), bis(Laspartato(2-)-kappaN,kappaO1)-, (T-4)-, dihydrogen, mixt. contg.
  • Spartase

Registry Numbers

CAS Registry Number

  • 14842-81-0

FDA UNII

  • 55TUI7Q42I

Other Registry Numbers

  • 39341-92-9
  • 8000-90-6
  • 8022-01-3

System Generated Number

  • 0014842810

Molecular Formulas

Molecular Formula

  • C8-H10-Mg-N2-O8.C4-H6-N-O4.2H.K

Molecular Formula Fragments

  • C4-H6-N-O4
  • C8-H10-Mg-N2-O8
  • COMPONENT
  • H
  • K

Structure Descriptors

InChI

1S/3C4H7NO4.K.Mg/c3*5-2(4(8)9)1-3(6)7;;/h3*2H,1,5H2,(H,6,7)(H,8,9);;/q;;;+1;+2/p-3/t2-;;;;/m0..../s1

InChIKey

KLISBMUDTJHGSP-AIDJSRAFSA-K

Smiles

C([C@@H](CC(=O)O)N)(=O)[O-].C(=O)([C@@H](CC(O)=O)N)[O-].C(C[C@@H](C(=O)[O-])N)(O)=O.[K+].[Mg+2]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous 817mg/kg (817mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.
mouse LD50 oral > 10gm/kg (10000mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.
mouse LD50 subcutaneous 4226mg/kg (4226mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.
rat LD50 intraperitoneal > 2gm/kg (2000mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 9, Pg. 759, 1967.
rat LD50 intravenous 619mg/kg (619mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.
rat LD50 oral > 10gm/kg (10000mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.
rat LD50 subcutaneous 6902mg/kg (6902mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.